Warburg Cuts Chinese Pharma Firm Stake With Hefty Windfall
March 4, 2016 — 08:53 CST
This Data Is Locked!
This area is available only to Subscribers.
Private equity firm Warburg Pincus has trimmed its stake in NASDAQ-listed China Biologic Products again, selling a 16% stake for US$425.7 million, according to a... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals